Skip to content
Rezafungin
Rezzayo (rezafungin) is a small molecule pharmaceutical. Rezafungin was first approved as Rezzayo on 2023-03-22.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Rezzayo
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Rezafungin acetate
Tradename
Company
Number
Date
Products
REZZAYOCidara TherapeuticsN-217417 RX2023-03-22
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
rezzayoNew Drug Application2023-06-08
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
REZAFUNGIN ACETATE, REZZAYO, CIDARA THERAPS
2035-03-22GAIN
2033-03-22GAIN
2030-03-22ODE-426
2028-03-22NCE
Patent Expiration
Patent
Expires
Flag
FDA Information
Rezafungin Acetate, Rezzayo, Cidara Theraps
111979092038-07-14DS, DPU-3566
95268352033-03-14DS, DPU-3566
107025732033-03-14DS, DPU-3566
87226192032-03-02DS, DPU-3566
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
8 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MycosesD009181B35-B49122——5
CandidemiaD058387EFO_1001282—12——3
Invasive candidiasisD058365EFO_1001283B37—12——3
FungemiaD016469B49—11——2
PneumocystisD011010——1——1
AspergillusD001230——1——1
Invasive hydatidiform moleD002820D39.2——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Vulvovaginal candidiasisD002181EFO_0007543B37.3—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—2————2
Invasive fungal infectionsD0000727421————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameREZAFUNGIN
INNrezafungin acetate
Description
Rezafungin (trade name Rezzayo) is an antifungal drug of the echinocandin class.
Classification
Small molecule
Drug classantifungal antibiotics (undefined group)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](OCC[N+](C)(C)C)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1
Identifiers
PDB—
CAS-ID1396640-59-7
RxCUI—
ChEMBL IDCHEMBL3989945
ChEBI ID—
PubChem CID92135635
DrugBankDB16310
UNII IDW1U1TMN677 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 298 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details